Addendum: MNTA’s Stifel webcast* might have been cancelled due to the McPherson situation, if MNTA knew then that there would be a longer delay. But, if that’s true, why has there been no 8-K issued yet?
While Momenta might release a 8-K regarding the Pfizer situation they really don't follow any certain religion when it comes to providing information.
It has always been said that the insider stock sales have followed a 10b5-1 stock trading plan which is the right way to do it.
Considering the Orencia Failure was announced the morning of the Q3 17' earning call and the Necuparanib Failure was announced the morning of the Q2 16' earnings call it would seem that Momenta releases its info at will.
An unlikely ray of hope? This is from the Nov 27th letter: "We will continue to manufacture and deliver select presentations throughout the upgrade work taking place but do anticipate backorders and product shortages. " It is now a week later and much later than the Stefel conference. One would think Momenta had an obligation to inform earlier and if they didn't perhaps the notation about "select presentation" includes copax 40. I know that is a pretty optimistic view insight of just how poorly things have gone. I can imaging Pfizer isn't on the hood for some measure of compensation for failure to deliver. It will be interesting to see what kind of damage control Craig comes up with. I suspect it will be an acceleration of Ivg programs as mentioned by others on this board. Regards, bp
News 
Market Data 
Discover 
